OTC Continuous Glucose Monitors: UK Guide

Over-the-counter continuous glucose monitors (CGMs) are wearable sensor devices that track glucose levels throughout the day and night, now available to buy in the UK without a prescription. Originally developed for people managing diabetes, consumer CGMs such as the Abbott FreeStyle Libre range are increasingly used by the general public for health and lifestyle monitoring. This article explains how OTC CGMs work, who can buy them, what they cost, how accurate they are, who might benefit from using one, and what side effects to watch for, helping you make an informed decision about whether a CGM is right for you.

What is an over-the-counter continuous glucose monitor?

An OTC CGM is a wearable adhesive sensor that measures interstitial glucose automatically at frequent intervals and transmits readings to a smartphone or reader, available to buy without a prescription. It remains a regulated medical device under UKCA or CE marking regardless of purchase route.

An over-the-counter continuous glucose monitor (CGM) is a wearable sensor device that measures glucose levels in the fluid just beneath the skin, available to buy without a prescription. Unlike a traditional fingerprick blood glucose meter, a CGM records glucose readings automatically at frequent intervals, typically every one to fifteen minutes, and transmits the data wirelessly to a smartphone app or dedicated reader.^[4] This gives the user a continuous picture of how their glucose levels rise and fall throughout the day and night, rather than isolated snapshots.

The sensor consists of a small adhesive patch with a tiny, flexible filament that sits just under the skin to measure interstitial glucose. Permitted wear sites vary by product and must be followed as set out in each device's Instructions for Use (IFU): for example, the Abbott FreeStyle Libre 2 and Libre 3 are approved for the back of the upper arm only. Most consumer CGM sensors last between ten and fourteen days before they need replacing.^[4] The device does not measure blood glucose directly; it measures glucose in the interstitial fluid, which lags slightly behind blood glucose, particularly during rapid changes such as after eating or during exercise.^[8][9]

In the UK, several CGM systems are available without a prescription, including the Abbott FreeStyle Libre range. These devices were originally developed for people managing diabetes but have since been made available to the general public as health-monitoring tools. It is important to understand that purchase route does not determine a device's regulatory classification: CGMs sold over the counter that carry a UKCA or CE mark remain regulated medical devices.^[1] Their intended purpose, as stated by the manufacturer, determines how they are classified and what claims can be made about them.

Can you buy a CGM without a prescription in the UK?

Yes, CGMs such as the Abbott FreeStyle Libre 2 and Libre 3 can be purchased without a prescription from UK pharmacies, supermarkets, and online retailers. People with diabetes may also access CGMs on the NHS if they meet NICE criteria and their ICB commissions the device.

Yes, certain CGM systems can be purchased without a prescription in the UK, from pharmacies, supermarkets, and online retailers. The Abbott FreeStyle Libre 2 and FreeStyle Libre 3 are currently available over the counter; earlier versions of the range have been progressively updated, so it is worth checking current availability with the retailer or manufacturer. These products are regulated as medical devices by the Medicines and Healthcare products Regulatory Agency (MHRA) and do not require a clinician's prescription to purchase.

For people living with type 1 or type 2 diabetes, CGMs may be available on the NHS. NICE guideline NG17 (Type 1 diabetes in adults) and NG28 (Type 2 diabetes in adults) set out the criteria under which CGM or flash glucose monitoring is recommended, and NHS England has issued commissioning guidance to support access for eligible groups.^[2][3] However, NHS provision is subject to local Integrated Care Board (ICB) commissioning decisions, and supply may be arranged through a GP, a specialist diabetes team, or a homecare service depending on local pathways. Not everyone who meets the clinical criteria will automatically receive a device, and charging arrangements differ across England, Scotland, Wales, and Northern Ireland. Those who do not qualify for NHS provision, or who wish to use a CGM for general health monitoring, can purchase devices privately.

When buying any CGM over the counter, check that the product carries a UKCA or CE mark, confirming it has met the relevant conformity standards for medical devices. CE marks continue to be recognised in Great Britain under current MHRA policy, alongside UKCA marking.^[1] Purchasing from a registered pharmacy or a reputable retailer reduces the risk of acquiring counterfeit or substandard products. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering health consultations, with prescriber review and pharmacist support, where clinically appropriate options can be discussed.

How much does an OTC continuous glucose monitor cost?

Individual CGM sensors typically cost approximately £35 to £50 each, lasting up to fourteen days, giving an indicative monthly cost of £70 to £100. People who qualify under NICE guidance may receive devices via NHS prescription, subject to standard prescription charges.

The cost of an over-the-counter CGM in the UK varies depending on the brand, sensor duration, and where it is purchased. Prices change regularly, so the figures below are indicative only and should be verified directly with the retailer or manufacturer before purchase.

As a general guide at the time of writing, individual sensors for the Abbott FreeStyle Libre range have typically been priced in the region of £35 to £50 per sensor, with each sensor lasting up to fourteen days, giving an approximate monthly cost of £70 to £100 for continuous monitoring. Some systems also require a separate reader device as a one-off purchase, though most modern CGMs can be used with a compatible smartphone, removing the need for a dedicated reader. It is worth comparing the total cost of ownership, including both the reader and ongoing sensor costs, before committing to a particular system.

For people with diabetes who qualify under NICE guidance and whose ICB commissions CGM, the device may be available on the NHS. Where supply is via a GP prescription in England, the standard NHS prescription charge applies; the current charge and the cost of a prescription prepayment certificate (PPC) are published by the NHS Business Services Authority (NHSBSA) at nhsbsa.nhs.uk and are updated periodically. Prescription charges differ across the UK nations, and devices supplied through secondary care or homecare services may not attract a per-item charge. People using CGMs purely for wellness monitoring will not qualify for NHS provision and will need to fund the cost privately.

How accurate are consumer CGMs compared to clinical devices?

Consumer CGMs are accurate enough for trend monitoring, with CE or UKCA-marked devices typically reporting MARD values of 7 to 9 percent, but they are not equivalent to laboratory blood glucose measurements. Interstitial glucose lags behind blood glucose by five to fifteen minutes, so a confirmatory fingerprick test is advisable if a reading does not match symptoms.

Consumer CGMs are generally accurate enough for trend monitoring and lifestyle awareness, but they are not equivalent in precision to laboratory blood glucose measurements. Accuracy in CGM technology is typically expressed using a metric called Mean Absolute Relative Difference (MARD): a lower MARD percentage indicates greater accuracy. Published clinical data for UKCA or CE-marked CGMs used in diabetes care, such as the Dexcom G7 and Abbott FreeStyle Libre 3, report MARD values broadly in the range of 7 to 9 percent; figures for individual devices are available in manufacturer-published accuracy data and peer-reviewed studies.^[7] It is worth noting that purchase route does not determine accuracy: a CGM that is available over the counter may use the same sensor technology as one supplied on prescription.

Several factors can affect CGM accuracy regardless of the device. These include:

• Compression artefacts: lying on the sensor during sleep can cause falsely low readings.

• Rapid glucose changes: interstitial glucose lags behind blood glucose by approximately five to fifteen minutes, so readings during fast rises or falls may not reflect the true blood level at that moment.^[8][9]

• Calibration: some devices require periodic fingerprick calibration to maintain accuracy, while others are factory-calibrated.

• Skin temperature and hydration: extremes of temperature or dehydration can affect sensor performance.

• Interfering substances: certain medicines and supplements can affect readings on some CGM models. High-dose vitamin C (ascorbic acid) is a known interferent for some sensors, and other substances are listed in individual product IFUs.^[10][11] Users should check the IFU for their specific device and perform a confirmatory fingerprick test if a reading does not match their symptoms.

For people without diabetes using a CGM for general wellness, the level of accuracy provided by these devices is generally sufficient for identifying patterns related to diet, exercise, and sleep. However, CGMs should not be used to make clinical decisions, such as adjusting insulin doses, without guidance from a healthcare professional. If readings are unexpectedly high or low, a confirmatory fingerprick test is advisable before acting on the result.

Who might benefit from using a CGM without a diagnosis?

People with prediabetes, a strong family history of type 2 diabetes, PCOS, or those focused on sports performance or weight management may find OTC CGM data informative for lifestyle decisions. CGM readings do not replace formal diabetes screening and anyone with consistently elevated readings should see their GP.

People without a formal diagnosis of diabetes may still find value in using a CGM to understand how their body responds to food, exercise, stress, and sleep. Some research suggests that glucose variability, even within the normal range, may influence energy levels, mood, and cognitive performance, though the clinical significance of these observations in people without metabolic disease is still an active area of investigation and should not be overstated.

Groups who may find OTC CGM use informative include:

• People with prediabetes or impaired fasting glucose: monitoring glucose trends can support dietary and lifestyle changes recommended by a GP or dietitian.

• Those with a strong family history of type 2 diabetes: CGM data may motivate earlier lifestyle intervention, though it does not replace formal screening through an NHS Health Check or a laboratory HbA1c or fasting plasma glucose test.

• Athletes and people focused on sports performance: some endurance athletes use CGMs to explore fuelling strategies around training, though evidence for performance benefit in people without diabetes remains limited.

• People managing weight: understanding postprandial glucose responses to different foods can complement dietary advice, though CGM is not a weight-management tool in isolation.

• Individuals with polycystic ovary syndrome (PCOS): given the association between PCOS and insulin resistance, some women use CGMs to monitor glucose patterns alongside medical management, though evidence in this group is still emerging.^[12][13]

A CGM reading is not a substitute for a formal diabetes diagnosis, which requires a laboratory HbA1c or fasting plasma glucose test interpreted by a clinician.^[2][3] Anyone who notices consistently elevated readings on a consumer CGM should contact their GP for formal assessment rather than self-diagnosing. Information on NHS diabetes testing and the NHS Health Check programme is available at nhs.uk.

What side effects and skin reactions should you watch for?

The most common side effects are localised skin redness, itching, and adhesive contact dermatitis at the sensor site, which usually resolve after sensor removal. Signs of infection such as increasing redness, swelling, warmth, or discharge require prompt medical advice, and reactions can be reported to the MHRA via the Yellow Card scheme.

The most commonly reported side effects from wearing a CGM are local skin reactions at the sensor insertion site, and these can occur with both prescription and over-the-counter devices. Most reactions are mild and resolve once the sensor is removed, but some users experience more persistent symptoms that warrant attention.

Common skin reactions include:

• Redness and irritation: mild erythema around the adhesive patch is common, particularly in people with sensitive skin.

• Itching: the adhesive or the sensor filament can cause localised pruritus, especially in warm weather when sweating increases.

• Skin indentation or bruising: minor bruising at the insertion site is possible, particularly if the sensor is placed over a blood vessel.

• Allergic contact dermatitis: some users develop a reaction to the adhesive materials used in the patch. This can present as a well-defined, raised, itchy rash that mirrors the shape of the sensor.^[16] If this occurs, the sensor should be removed and the reaction reviewed by a pharmacist or GP.

More serious reactions are uncommon but include infection at the insertion site, characterised by increasing redness, warmth, swelling, or discharge. If any of these signs develop, the sensor should be removed and medical advice sought from a GP. If there are signs of a spreading infection or systemic symptoms such as fever, contact NHS 111 for urgent advice.

To minimise skin reactions, always follow the skin preparation, application, and removal steps in your device's IFU, as these differ between products. Permitted wear sites also vary by device and must be followed as instructed. Rotate the sensor site with each replacement, ensure the skin is clean and dry before application, and avoid applying the sensor over broken, irritated, or tattooed skin. People with known adhesive allergies should discuss barrier film options with a pharmacist before starting CGM use.

Suspected adverse reactions to a medical device can be reported to the MHRA via the Yellow Card scheme at yellowcard.^[5][6]mhra.gov.uk.

Scientific References

1. Regulating medical devices in the UK.
2. Type 1 diabetes in adults: diagnosis and management (NG17).
3. Type 2 diabetes in adults: management (NG28).
4. Continuous glucose monitoring and hybrid closed loop for diabetes.
5. The Yellow Card scheme: guidance for healthcare professionals, patients and the public.
6. Adverse reactions to drugs.
7. Comparison of Point Accuracy Between Two Widely Used Continuous Glucose Monitoring Systems (FreeStyle Libre 3 vs Dexcom G7).
8. Time lag of glucose from intravascular to interstitial compartment in type 1 diabetes.
9. Breaking through lag: enhancing intradermal electro-osmotic flow and the future of delay-free continuous glucose monitoring.
10. Impact of Ascorbic Acid and Exercise on Accuracy of a Glucose Monitoring System with GDH-FAD Technology in Adult Patients with Type 1 Diabetes Mellitus: A Double-Blinded, Randomized Trial.
11. GlucoMen Day continuous glucose monitoring system: a screening for enzymatic and electrochemical interferents.
12. Polycystic ovary syndrome (PCOS): assessment and management — consultation comments and responses.
13. Polyendocrine metabolic ovarian syndrome (PMOS).
14. The impact of gut microbiota on insulin resistance in polycystic ovary syndrome: mechanisms and therapeutic prospects.
15. Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk.
16. High Prevalence of Skin Reactions Among Pediatric Patients with Type 1 Diabetes Using New Technologies: The Alarming Role of Colophonium.

Frequently Asked Questions